Skip to main content

Advertisement

Log in

Formulation and Evaluation of Chitosan-Based Buccal Bioadhesive Films of Zolmitriptan

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Therapeutic efficacy of zolmitriptan in oral therapy is primarily limited by the biopharmaceutical issues. The objective of this study is to design and optimize chitosan-based buccal bioadhesive system for the effective delivery of zolmitriptan in the treatment of migraine.

Methods

Factorial design (32) is constructed and conducted in a fully randomized manner to study all nine possible experimental runs. The films were prepared by solvent casting method by varying the content of chitosan (X1) and polyvinyl alcohol (X2). The effect of these two independent variables on swelling index (Y1), percent drug release in 15 min (Y2) and 5 h (Y3), and mucoadhesive strength (Y4) of prepared films was evaluated.

Results

The physical and chemical characteristics displayed by the prepared films (F1–F9) were found to be optimal. It was observed that the factor X1 has positive and X2 has negative effect on response Y1. In contrast, factor X1 showed negative effects on drug release at both time intervals (15 min and 5 h) while X2 displayed positive responses for these variables (Y2 and Y3). However, the mucoadhesion increased with an increase in factor X1 and decreased when the factor X2 was increased. Indeed, the desirable characteristics exhibited by the film F7 are ideal for buccal application. Greater flux (63.93 ± 12.51 μg/cm2/h) demonstrated in ex vivo studies substantiated the potential of optimized film to effectively deliver zolmitriptan across the buccal membrane.

Conclusions

This study concludes that the chitosan-based buccal film (F7) could be used in both prophylaxis and acute treatment of migraine, although need to be proved in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Antonaci F, Dumitrache C, De Cillis I, Allena M. A review of current European treatment guidelines for migraine. J Headache Pain. 2010;11(1):13–9. https://doi.org/10.1007/s10194-009-0179-2.

    Article  PubMed  Google Scholar 

  2. Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–29. https://doi.org/10.1523/JNEUROSCI.0373-15.2015.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Freitag FG. The cycle of migraine: patients’ quality of life during and between migraine attacks. Clin Ther. 2007;29(5):939–49. https://doi.org/10.1016/j.clinthera.2007.05.008.

    Article  PubMed  Google Scholar 

  4. Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(Suppl 1):S15–22. https://doi.org/10.4103/0972-2327.99993.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Becker WJ. Acute migraine treatment in adults. Headache. 2015;55(6):778–93. https://doi.org/10.1111/head.12550.

    Article  PubMed  Google Scholar 

  6. Tepper SJ, Rapoport AM, Sheftell FD. Mechanisms of action of the 5-HT1B/1D receptor agonists. Arch Neurol. 2002;59(7):1084–8. https://doi.org/10.1001/archneur.59.7.1084.

    Article  PubMed  Google Scholar 

  7. Antonaci F, Ghiotto N, Wu S, Pucci E, Costa A. Recent advances in migraine therapy. Spring. 2016;5(1):637. https://doi.org/10.1186/s40064-016-2211-8.

    Article  CAS  Google Scholar 

  8. Dowson AJ, Charlesworth B. Review of zolmitriptan and its clinical applications in migraine. Expert Opin Pharmacother. 2002;3(7):993–1005. https://doi.org/10.1517/14656566.3.7.993.

    Article  PubMed  CAS  Google Scholar 

  9. Goadsby PJ, Boes CJ. Zolmitriptan: differences from sumatriptan. Curr Med Res Opin. 2001;17(Suppl 1):s46–50. https://doi.org/10.1185/0300799039117013.

    Article  PubMed  Google Scholar 

  10. Koteswari P, Sravanthi GP, Mounika M, Mohammed Rafi SK, Nirosha K. Formulation development and evaluation of zolmitriptan oral soluble films using 22 factorial designs. Int J Pharm Investig. 2016;6(4):201–6. https://doi.org/10.4103/2230-973X.195927.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Liu C, Fang L. Drug in adhesive patch of zolmitriptan: formulation and in vitro/in vivo correlation. AAPS PharmSciTech. 2015;16(6):1245–53. https://doi.org/10.1208/s12249-015-0303-3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Shiledar RR, Tagalpallewar AA, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym. 2014;101:1234–42. https://doi.org/10.1016/j.carbpol.2013.10.072.

    Article  PubMed  CAS  Google Scholar 

  13. Kassem AA. Formulation approaches of triptans for management of migraine. Curr Drug Deliv. 2016;13(6):882–98. https://doi.org/10.2174/1567201813666160425112600.

    Article  PubMed  CAS  Google Scholar 

  14. Al-Dhubiab BE, Nair AB, Kumria R, Attimarad M, Harsha S. Development and evaluation of buccal films impregnated with selegiline-loaded nanospheres. Drug Deliv. 2016;23(7):2154–62. https://doi.org/10.3109/10717544.2014.948644.

    Article  PubMed  CAS  Google Scholar 

  15. Scholz OA, Wolff A, Schumacher A, Giannola LI, Campisi G, Ciach T, et al. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug Discov Today. 2008;13(5–6):247–53. https://doi.org/10.1016/j.drudis.2007.10.018.

    Article  PubMed  CAS  Google Scholar 

  16. Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv. 2016;23(2):471–8. https://doi.org/10.3109/10717544.2014.920058.

    Article  PubMed  CAS  Google Scholar 

  17. Montenegro-Nicolini M, Morales JO. Overview and future potential of buccal mucoadhesive films as drug delivery systems for biologics. AAPS PharmSciTech. 2017;18(1):3–14. https://doi.org/10.1208/s12249-016-0525-z.

    Article  PubMed  CAS  Google Scholar 

  18. Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 2014;28(2):81–97. https://doi.org/10.7555/JBR.27.20120136.

    Article  PubMed  Google Scholar 

  19. Kumar S, Gupta SK. Natural polymers, gums and mucilages as excipients in drug delivery. Polim Med. 2012;42(3–4):191–7.

    PubMed  CAS  Google Scholar 

  20. Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, properties and applications. Mar Drugs. 2015;13(3):1133–74. https://doi.org/10.3390/md13031133.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Cheung RC, Ng TB, Wong JH, Chan WY. Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs. 2015;13(8):5156–86. https://doi.org/10.3390/md13085156.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Islam MA, Park TE, Reesor E, Cherukula K, Hasan A, Firdous J, et al. Mucoadhesive chitosan derivatives as novel drug carriers. Curr Pharm Des. 2015;21(29):4285–309. https://doi.org/10.2174/1381612821666150901103819.

    Article  PubMed  CAS  Google Scholar 

  23. Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463–9. https://doi.org/10.1016/j.ejpb.2012.04.007.

    Article  PubMed  CAS  Google Scholar 

  24. Duttagupta DS, Jadhav VM, Kadam VJ. Chitosan: a propitious biopolymer for drug delivery. Curr Drug Deliv. 2015;12(4):369–81. https://doi.org/10.2174/1567201812666150310151657.

    Article  PubMed  CAS  Google Scholar 

  25. Al-Dhubiab BE. Aripiprazole nanocrystal impregnated buccoadhesive films for schizophrenia. J Nanosci Nanotechnol. 2017;17(4):2345–52. https://doi.org/10.1166/jnn.2017.12588.

    Article  PubMed  CAS  Google Scholar 

  26. Kumria R, Nair AB, Al-Dhubiab BE. Loratidine buccal films for allergic rhinitis: development and evaluation. Drug Dev Ind Pharm. 2014;40(5):625–31. https://doi.org/10.3109/03639045.2014.884125.

    Article  PubMed  CAS  Google Scholar 

  27. Nair AB, Al-Ghannam AA, Al-Dhubiab BE, Hasan AA. Mucoadhesive film embedded with acyclovir loaded biopolymeric nanoparticles: in vitro studies. J Young Pharm. 2017;9(1):100–5. https://doi.org/10.5530/jyp.2017.9.19.

    Article  CAS  Google Scholar 

  28. Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166(1):10–21. https://doi.org/10.1016/j.jconrel.2012.11.019.

    Article  PubMed  CAS  Google Scholar 

  29. Jug M, Hafner A, Lovrić J, Kregar ML, Pepić I, Vanić Ž, et al. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems. J Pharm Biomed Anal. 2018;147:350–66. https://doi.org/10.1016/j.jpba.2017.06.072.

    Article  PubMed  CAS  Google Scholar 

  30. Al-Dhubiab BE, Nair AB, Kumria R, Attimarad M, Harsha S. Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir. Colloids Surf B Biointerfaces. 2015;136:878–84. https://doi.org/10.1016/j.colsurfb.2015.10.045.

    Article  PubMed  CAS  Google Scholar 

  31. Nair AB, Sammeta SM, Vaka SRK, Murthy SN. A study on the effect of inorganic salts in transungual drug delivery of terbinafine. J Pharm Pharmacol. 2009;61(4):431–7. https://doi.org/10.1211/jpp.61.04.0003.

    Article  PubMed  CAS  Google Scholar 

  32. Shidhaye SS, Saindane NS, Sutar S, Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate. AAPS PharmSciTech. 2008;9(3):909–16. https://doi.org/10.1208/s12249-008-9125-x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Nair A, Gupta R, Vasanti S. In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product. Pharm Dev Technol. 2007;12(6):621–5. https://doi.org/10.1080/10837450701563277.

    Article  PubMed  CAS  Google Scholar 

  34. Kumria R, Gupta V, Bansal S, Wadhwa J, Nair AB. Oral buccoadhesive films of ondansetron: development and evaluation. Int J Pharm Investig. 2013;3(2):112–8. https://doi.org/10.4103/2230-973X.114894.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Al-Dhubiab BE, Nair AB, Kumria R, Attimarad M, Harsha S. Development and evaluation of nebivolol hydrochloride nanocrystals impregnated buccal film. Farmacia. 2017; In press.

  36. Pathak K, Sharma V, Akhtar N, Rastogi P. Localization of fluconazole in oral cavity by preferential coating of buccoadhesive tablet for treatment of oral thrush. Int J Pharm Investig. 2016;6(2):106–15. https://doi.org/10.4103/2230-973X.177826.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Panigrahi L, Pattnaik S, Ghosal SK. Design and characterization of mucoadhesive buccal patches of salbutamol sulphate. Acta Pol Pharm. 2004 Sep-Oct;61(5):351–60.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the Deanship of Scientific Research, King Faisal University (project no. 170078) for the financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anroop B Nair.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumria, R., Al-Dhubiab, B.E., Shah, J. et al. Formulation and Evaluation of Chitosan-Based Buccal Bioadhesive Films of Zolmitriptan. J Pharm Innov 13, 133–143 (2018). https://doi.org/10.1007/s12247-018-9312-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-018-9312-6

Keywords

Navigation